154 related articles for article (PubMed ID: 32587285)
1. Risk of Ischemic Heart Disease and Stroke in Prostate Cancer Survivors: A Nationwide Study in South Korea.
Shin DW; Han K; Park HS; Lee SP; Park SH; Park J
Sci Rep; 2020 Jun; 10(1):10313. PubMed ID: 32587285
[TBL] [Abstract][Full Text] [Related]
2. Risk of fracture incidence in prostate cancer survivors: a nationwide cohort study in South Korea.
Shin HB; Park HS; Yoo JE; Han K; Park SH; Shin DW; Park J
Arch Osteoporos; 2020 Jul; 15(1):110. PubMed ID: 32700143
[TBL] [Abstract][Full Text] [Related]
3. Risk of dementia in prostate cancer survivors: A nationwide cohort study in Korea.
Kang J; Shin DW; Han K; Park SH; Lee WG; Yoo JE; Woo SH; Park J
Curr Probl Cancer; 2020 Dec; 44(6):100578. PubMed ID: 32360240
[TBL] [Abstract][Full Text] [Related]
4. Does androgen-deprivation therapy increase the risk of ischemic cardiovascular and cerebrovascular diseases in patients with prostate cancer? A nationwide population-based cohort study.
Kim DK; Lee HS; Park JY; Kim JW; Ha JS; Kim JH; Yang WJ; Cho KS
J Cancer Res Clin Oncol; 2021 Apr; 147(4):1217-1226. PubMed ID: 33000338
[TBL] [Abstract][Full Text] [Related]
5. Increased risk of coronary heart disease and stroke in lung cancer survivors: A Korean nationwide study of 20,458 patients.
Yoon DW; Shin DW; Cho JH; Yang JH; Jeong SM; Han K; Park SH
Lung Cancer; 2019 Oct; 136():115-121. PubMed ID: 31493668
[TBL] [Abstract][Full Text] [Related]
6. Ischemic heart disease and stroke before and during endocrine treatment for prostate cancer in PCBaSe Sweden.
Robinson D; Garmo H; Lindahl B; Van Hemelrijck M; Adolfsson J; Bratt O; Holmberg L; Stattin P
Int J Cancer; 2012 Jan; 130(2):478-87. PubMed ID: 21387298
[TBL] [Abstract][Full Text] [Related]
7. Risk of ischemic stroke in patients with prostate cancer receiving androgen deprivation therapy in Taiwan.
Liao KM; Huang YB; Chen CY; Kuo CC
BMC Cancer; 2019 Dec; 19(1):1263. PubMed ID: 31888558
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular risk of gonadotropin-releasing hormone antagonist versus agonist in men with prostate cancer: an observational study in Taiwan.
Shao YJ; Hong JH; Chen CK; Huang CY
Prostate Cancer Prostatic Dis; 2023 Dec; 26(4):722-729. PubMed ID: 35662291
[TBL] [Abstract][Full Text] [Related]
9. Is androgen deprivation therapy associated with cerebral infarction in patients with prostate cancer? A Korean nationwide population-based propensity score matching study.
Tae BS; Jeon BJ; Choi H; Bae JH; Park JY
Cancer Med; 2019 Aug; 8(9):4475-4483. PubMed ID: 31183968
[TBL] [Abstract][Full Text] [Related]
10. Risk of Coronary Heart Disease and Ischemic Stroke Incidence in Gastric Cancer Survivors: A Nationwide Study in Korea.
Shin DW; Suh B; Park Y; Lim H; Suh YS; Yun JM; Cho B; Yang HK
Ann Surg Oncol; 2018 Oct; 25(11):3248-3256. PubMed ID: 30043317
[TBL] [Abstract][Full Text] [Related]
11. Stroke and thromboembolic events in men with prostate cancer treated with definitive radiation therapy with or without androgen deprivation therapy.
Deka R; Simpson DR; Panizzon MS; Hauger RL; Riviere P; Nalawade V; McKay R; Murphy JD; Rose BS
Prostate Cancer Prostatic Dis; 2019 Dec; 22(4):600-608. PubMed ID: 30988408
[TBL] [Abstract][Full Text] [Related]
12. Androgen-deprivation therapy in treatment of prostate cancer and risk of myocardial infarction and stroke: a nationwide Danish population-based cohort study.
Jespersen CG; Nørgaard M; Borre M
Eur Urol; 2014 Apr; 65(4):704-9. PubMed ID: 23433805
[TBL] [Abstract][Full Text] [Related]
13. Long-term Risks of Depression and Suicide Among Men with Prostate Cancer: A National Cohort Study.
Crump C; Stattin P; Brooks JD; Sundquist J; Bill-Axelson A; Edwards AC; Sundquist K; Sieh W
Eur Urol; 2023 Sep; 84(3):263-272. PubMed ID: 37169640
[TBL] [Abstract][Full Text] [Related]
14. Androgen-deprivation therapy and the risk of stroke in patients with prostate cancer.
Azoulay L; Yin H; Benayoun S; Renoux C; Boivin JF; Suissa S
Eur Urol; 2011 Dec; 60(6):1244-50. PubMed ID: 21908097
[TBL] [Abstract][Full Text] [Related]
15. Androgen-deprivation therapy and risk of death from cardio-vascular disease in prostate cancer patients: a nationwide lithuanian population-based cohort study.
Jonušas J; Drevinskaitė M; Patašius A; Kinčius M; Janulionis E; Smailytė G
Aging Male; 2022 Dec; 25(1):173-179. PubMed ID: 35882633
[No Abstract] [Full Text] [Related]
16. Increased Risk of Osteoporotic Fracture in Postgastrectomy Gastric Cancer Survivors Compared With Matched Controls: A Nationwide Cohort Study in Korea.
Shin DW; Suh B; Lim H; Suh YS; Choi YJ; Jeong SM; Yun JM; Song SO; Park Y
Am J Gastroenterol; 2019 Nov; 114(11):1735-1743. PubMed ID: 31658122
[TBL] [Abstract][Full Text] [Related]
17. Hormone therapy for prostate cancer and the risk of stroke: a 5-year follow-up study.
Chung SD; Chen YK; Wu FJ; Lin HC
BJU Int; 2012 Apr; 109(7):1001-5. PubMed ID: 21883836
[TBL] [Abstract][Full Text] [Related]
18. Androgen deprivation therapy for prostate cancer and the risk of hematologic disorders.
Liu JM; Liu YP; Chuang HC; Wu CT; Su YL; Hsu RJ
PLoS One; 2020; 15(2):e0229263. PubMed ID: 32074125
[TBL] [Abstract][Full Text] [Related]
19. No increased risk of dementia in patients receiving androgen deprivation therapy for prostate cancer: a 5-year follow-up study.
Kao LT; Lin HC; Chung SD; Huang CY
Asian J Androl; 2017; 19(4):414-417. PubMed ID: 27232853
[TBL] [Abstract][Full Text] [Related]
20. Androgen deprivation therapy and cardiovascular risk: No meaningful difference between GnRH antagonist and agonists-a nationwide population-based cohort study based on 2010-2013 French Health Insurance data.
Scailteux LM; Vincendeau S; Balusson F; Leclercq C; Happe A; Le Nautout B; Polard E; Nowak E; Oger E
Eur J Cancer; 2017 May; 77():99-108. PubMed ID: 28390298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
